383 results on '"Mabuchi, S."'
Search Results
52. Prognostic factors for survival in cervical cancer patients with bone metastasis
- Author
-
Kanayama T, Mabuchi S, Shimura K, Hisamatsu T, Isohashi F, Toshimitsu Hamasaki, and Kimura T
- Subjects
Adult ,Aged, 80 and over ,Salvage Therapy ,Palliative Care ,Uterine Cervical Neoplasms ,Antineoplastic Agents ,Bone Neoplasms ,Chemoradiotherapy ,Adenocarcinoma ,Middle Aged ,Hysterectomy ,Prognosis ,Carcinoma, Adenosquamous ,Carcinoma, Squamous Cell ,Humans ,Female ,Aged ,Retrospective Studies - Abstract
To investigate the prognostic factors for survival in uterine cervical cancer patients who developed bone metastasis.Cervical cancer patients with bone metastasis who were treated at the present institute from April 1996 to September 2010 were identified from the authors' institutional tumor registries. Primary disease, follow-up, and recurrence data were collected and retrospectively reviewed. Univariate and multivariate analyses of prognostic factors for survival were performed.A total of 37 patients that developed cervical cancer bone metastasis were included in the authors' database. The median survival time after recurrence was 12 months. Univariate analysis revealed that patients with a disease-free interval (DFI) of ten months or less achieved significantly shorter survival after bone metastasis detection than those with a DFI of 11 months or more (median: 8.5 months versus 17 months, p0.0001). Multivariate analysis also showed that DFI of ten months or less was a significant predictor of short survival (p = 0.0018).The DFI was found to be independent prognostic factors for survival in cervical cancer patients who developed bone metastasis.
53. Condyloma acuminata induces focal intense FDG uptake mimicking vaginal stump recurrence from uterine cervical cancer: a case report.
- Author
-
Kishimoto, T., Mabuchi, S., Kato, H., and Kimura, T.
- Subjects
- *
CERVICAL cancer patients , *DRUG therapy , *RADIOTHERAPY - Abstract
The article presents a case study of a 31 year old woman with Federation of Gynecology and Obstetrics (FIGO) Stage IB2 squamous cell carcinoma of the uterine cervix. It mentions that several treatment procedures regarding the disease including radical hysterectomy, consolidation chemotherapy and chemoradiotherapy. It discusses the importance of considering condyloma acuminata during the diagnosis of abnormal vaginal FDG uptake in gynecological cancer patients.
- Published
- 2013
54. Calcaneal metastasis in uterine cervical cancer: a case report and a review of the literature.
- Author
-
Kanayama, T., Mabuchi, S., Fujita, M., and Kimura, T.
- Subjects
- *
ONCOLOGIC surgery , *RADIOGRAPHY , *DRUG therapy - Abstract
The article presents a case study of a 64-year-old woman with diagnosed International Federation of Gynecologists and Obstetricians (FIGO) Stage IB2 cervical cancer and treated with radical surgery. The patient developed calcaneal metastasis six months following the initial surgery. The patient was relief from bone pain with palliative radiography and platinum-based combination chemotherapy.
- Published
- 2012
55. G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature.
- Author
-
Mabuchi, S., Morimoto, A., Fujita, M., Isohashi, K., and Kimura, T.
- Subjects
- *
CERVICAL cancer , *GRANULOCYTE-colony stimulating factor , *BONE metastasis , *COLONY-stimulating factors (Physiology) , *POSITRON emission tomography - Abstract
The article describes a case of FIGO Stage IB2 uterine cervical cancer which showed focal intense bone marrow F-18-fluorodeoxyglugose (FDG) uptake mimicking bone metastases following administration of granulocyte colony-stimulating factor (G-CSF) in a 50-year-old woman. The patient's clinical presentation and therapeutic management are described. It is noted that the case suggests the importance of avoiding the administration of G-CSF before positron emission tomography (PET) imaging.
- Published
- 2012
56. ChemInform Abstract: Conversion of 2-Methylthio-4-trifluoroacetyl-5,6-dihydro-4H-1,3,4-thiadiazines into α,β-Unsaturated Esters via Carbanion-Induced Ring Opening and Desulfurization.
- Author
-
SHIMADA, K., OTAKI, A., YANAKAWA, M., MABUCHI, S., YAMAKADO, N., SHIMOGUCHI, T., and TAKIKAWA, Y.
- Published
- 1998
- Full Text
- View/download PDF
57. Erratum to ''An interpretation of membership functions and the properties of general probabilistic operators as fuzzy set operators. (II). Extension to three-valued and interval-valued fuzzy sets'' [Fuzzy Sets and Systems 92 (1997) 31-50]
- Author
-
Mabuchi, S.
- Published
- 1999
- Full Text
- View/download PDF
58. Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.
- Author
-
Kunimasa K, Sugimoto N, Yamasaki T, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Kitasaka M, Sakai D, Honma K, Wakamatsu T, Yamamoto S, Hayashi T, Mabuchi S, Okuno J, Kawamura T, Kai Y, Urabe M, and Nishimura K
- Subjects
- Humans, Male, Female, Japan, Middle Aged, Aged, Adult, Aged, 80 and over, Progression-Free Survival, Young Adult, Genomics methods, Treatment Outcome, Biomarkers, Tumor genetics, Neoplasms genetics, Neoplasms therapy, Precision Medicine methods
- Abstract
Introduction: Comprehensive genome profiling (CGP) has revolutionized healthcare by offering personalized medicine opportunities. However, its real-world utility and impact remain incompletely understood. This study examined the extent to which CGP leads to genomically matched therapy and its effectiveness., Methods: We analyzed data from advanced solid tumor patients who underwent CGP panel between December 2019 and May 2023 at the Osaka International Cancer Institute. Patient demographics, specimen details, and expert panel assessments were collected. Turnaround time (TAT) and genomically matched therapy outcomes were analyzed. Gene alterations and their co-occurrence patterns were also assessed., Results: Among 1437 patients, 1096 results were available for analysis. The median TAT was 63 [28-182] days. There were 667 (60.9%) cases wherein recommended clinical trials were presented and there were 12 (1.1%) cases that could be enrolled in the trial and 25 (2.3%) cases that could lead to therapies under insurance reimbursement. The median progression free survival of the trial treatment was 1.58 months (95% CI: 0.66-4.37) in clinical trials and 3.66 months (95% CI: 2.14-7.13) in treatment under insurance. Pathologic germline variants were confirmed in 15 patients (1.3%). Co-alteration of CDKN2A, CDKN2B, and MTAP was significantly observed in overall population., Conclusion: The effectiveness of the genomically matched therapy based on the CGP panel was unsatisfactory. Expansion of clinical trials and utilization of remote clinical trials are required to ensure that the results of the CGP panel can be fully returned to patients., (© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
59. Facilitators, barriers, and changes in POCUS use: longitudinal follow-up after participation in a national point-of-care ultrasound training course in Japan.
- Author
-
Yamada T, Soni NJ, Minami T, Kitano Y, Yoshino S, Mabuchi S, and Hashimoto M
- Abstract
Background: POCUS training courses are effective at improving knowledge and skills, but few studies have followed learners longitudinally post-course to understand facilitators, barriers, and changes in POCUS use in clinical practice. We conducted a prospective observational study of physicians who attended 11 standardized POCUS training courses between 2017 and 2019 in Japan. Physicians who attended a standardized POCUS course were surveyed about their current frequency of POCUS use of the heart, lung, abdomen, and lower extremity veins, and perceived barriers and facilitators to POCUS use in clinical practice., Results: Data were analyzed from 112 completed surveys (response rate = 20%). A majority of responding physicians were faculty (77%) in internal medicine (69%) affiliated with community hospitals (55%). The mean delay between course attendance and survey response was 50.3 months. A significant increase in POCUS use from < 1 to ≥ 1 time per week was seen for all organ systems after 50 months post-course (p < 0.01). Approximately half of course participants reported an increase in the frequency of cardiac (61%), lung (53%), vascular (44%), and abdominal (50%) ultrasound use. General facilitators of POCUS use were easy access to ultrasound machines (63%), having a colleague with whom to learn POCUS (47%), and adequate departmental support (46%). General barriers included lack of opportunities for POCUS training (47%), poor access to ultrasound machines (38%), and limited time for POCUS training (33%). In the group with increased POCUS usage, specific facilitators reported were enhanced POCUS knowledge, improved image acquisition skills, and greater self-confidence in performing POCUS. Conversely, the group without increased POCUS usage reported lack of supervising physicians, low confidence, and insufficient training opportunities as specific barriers., Conclusions: Approximately half of physicians reported an increase in cardiac, lung, vascular, and abdominal POCUS use > 4 years after attending a POCUS training course. In addition to improving access to ultrasound machines and training opportunities, a supportive local clinical environment, including colleagues to share experiences in learning POCUS and local experts to supervise scanning, is important to foster ongoing POCUS practice and implementation into clinical practice., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
60. Extraovarian seromucinous borderline tumor: Case report and literature review.
- Author
-
Sakata M, Mabuchi S, Maeda M, Nagata S, Tanaka J, and Kamiura S
- Subjects
- Humans, Female, Adult, Middle Aged, Hysterectomy, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms surgery, Uterine Cervical Neoplasms diagnosis
- Abstract
Seromucinous borderline tumors (SMBT) are papillary neoplasms without invasive capabilities. Originally categorized as ovarian tumors, SMBT, being an endometriosis-related tumor, can manifest beyond the ovaries. To date, only four cases of extraovarian SMBT have been documented in literature. In this report, we present our experience with the first case of SMBT in the uterine cervix, which exhibited highly elevated CA19-9 levels. The patient, initially clinically diagnosed with cervical cancer, underwent treatment with radical hysterectomy and was later pathologically diagnosed with SMBT of the uterine cervix. While extraovarian SMBT, especially in the uterine cervix, is extremely rare, this condition should be considered in patients with cervical masses lacking pathological evidence of malignant disease but displaying elevated CA19-9 levels., (© 2024 Japan Society of Obstetrics and Gynecology.)
- Published
- 2024
- Full Text
- View/download PDF
61. Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study.
- Author
-
Sasano T, Mabuchi S, Komura N, Sakata M, Kamiura S, Morishima T, and Miyashiro I
- Subjects
- Humans, Female, Japan epidemiology, Middle Aged, Retrospective Studies, Adult, Incidence, Registries, Antineoplastic Agents, Hormonal therapeutic use, Aged, Carcinoma, Endometrioid epidemiology, Carcinoma, Endometrioid pathology, Carcinoma, Endometrioid therapy, Endometrial Neoplasms epidemiology, Endometrial Neoplasms pathology, Endometrial Neoplasms therapy
- Abstract
Background: We aimed to investigate the trends in the incidence and treatment of endometrial cancer (EC) during potentially reproductive age in Japan, with a special focus on the relative oncologic safety of hormonal therapy (HT) over surgery., Methods: This population-based retrospective cohort study was conducted using data from the Osaka Cancer Registry from 2004 to 2018. Women with EC were first identified and then distributions of age, stage, histology, and initial treatment were examined. Then, the relative oncologic safety of HT over surgery in patients under the age of 50 years was evaluated., Results: Among the 9417 patients with EC, 1937 were diagnosed during their potentially reproductive age (< 50 years). The incidence of EC during potentially reproductive age has increased from 18.5% in 2004-2011 to 21.9% in 2012-2018. ECs during potentially reproductive age more frequently displayed favorable characteristics, such as endometrioid histology, and lower histological grade than those in non-potentially reproductive age. Among the 1223 patients diagnosed with localized endometrioid EC, 74 cases (6.0%) received HT as an initial treatment, while 1100 cases (90.0%) underwent surgery as their initial treatment. When the two treatment groups were compared, there was no significant difference in overall survival (p = 0.3713). The estimated 5-year survival rates were 100 and 98.8% in the HT and surgery groups, respectively., Conclusion: EC is increasingly diagnosed during potentially reproductive age in Japan. The use of HT as an initial treatment is increasing, and achieved comparable survival outcomes to urgery against localized endometrioid EC during the potentially reproductive age., (© 2024. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
62. Relationship Between Diaphragm Thickness, Thickening Fraction, Dome Excursion, and Respiratory Pressures in Healthy Subjects: An Ultrasound Study.
- Author
-
Yamada T, Minami T, Yoshino S, Emoto K, Mabuchi S, Hanazawa R, Hirakawa A, and Hashimoto M
- Subjects
- Male, Adult, Humans, Healthy Volunteers, Respiratory Function Tests, Ultrasonography, Diaphragm diagnostic imaging, Exhalation
- Abstract
Purpose: Diaphragm ultrasonography is used to identify causes of diaphragm dysfunction. However, its correlation with pulmonary function tests, including maximal inspiratory (MIP) and expiratory pressures (MEP), remains unclear. This study investigated this relationship by measuring diaphragm thickness, thickening fraction (TF), and excursion (DE) using ultrasonography, and their relationship to MIP and MEP. It also examined the influence of age, sex, height, and BMI on these measures., Methods: We recruited healthy Japanese volunteers and conducted pulmonary function tests and diaphragm ultrasonography in a seated position. Diaphragm ultrasonography was performed during quiet breathing (QB) and deep breathing (DB) to measure the diaphragm thickness, TF, and DE. A multivariate analysis was conducted, adjusting for age, sex, height, and BMI., Results: Between March 2022 and January 2023, 109 individuals (56 males) were included from three facilities. The mean (standard deviation) MIP and MEP [cmH2O] were 72.2 (24.6) and 96.9 (35.8), respectively. Thickness [mm] at the end of expiration was 1.7 (0.4), TF [%] was 50.0 (25.9) during QB and 110.7 (44.3) during DB, and DE [cm] was 1.7 (0.6) during QB and 4.4 (1.4) during DB. Multivariate analysis revealed that only DE (DB) had a statistically significant relationship with MIP and MEP (p = 0.021, p = 0.008). Sex, age, and BMI had a statistically significant influence on relationships between DE (DB) and MIP (p = 0.008, 0.048, and < 0.001, respectively)., Conclusion: In healthy adults, DE (DB) has a relationship with MIP and MEP. Sex, age, and BMI, but not height, are influencing factors on this relationship., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
63. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
- Author
-
Maeda M, Mabuchi S, Sakata M, Deguchi S, Kakubari R, Matsuzaki S, Hisa T, and Kamiura S
- Subjects
- Humans, Female, Neoplasm Staging, Retrospective Studies, Prognosis, Lymph Nodes pathology, Uterine Cervical Neoplasms pathology
- Abstract
Objective: This study aimed to investigate the prognostic significance of tumor size and number of positive pelvic lymph nodes (PLN) in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIIC1 cervical cancer patients., Methods: Clinical data from 626 women with cervical cancer treated at Osaka International Cancer Center in 2010-2020 were retrospectively reviewed. Using the cutoff value obtained on the receiver operating characteristic analysis, the prognostic significance of tumor size and number of positive PLN in stage IIIC1 patients was first evaluated via uni- and multivariate analyses. Then, the impact of incorporating tumor size and number of positive PLN into the FIGO staging system was investigated using the Kaplan-Meier method., Results: Among 196 women with Stage IIIC1 disease, larger tumors (>4 cm) and multiple PLN metastases (≥4) were independent predictors of progression-free survival (PFS) in patients with stage IIIC1 cervical cancer. The PFS of patients with stage IIIC1 disease was inversely associated with the number of risk factors. Although patients with stage IIIC1 disease had significantly increased survival rates compared to those with stage IIIA or IIIB disease in the original FIGO 2018 staging system, this reversal phenomenon was resolved by incorporating larger tumors (>4 cm) and multiple PLN metastases (≥4) into the revised staging system., Conclusions: Incorporating tumor size and number of metastatic lymph nodes into the FIGO staging system allows additional risk stratification for women with stage IIIC1 cervical cancer and improves survival prediction performance., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
64. Diaphragm Ultrasonography: Reference Values and Influencing Factors for Thickness, Thickening Fraction, and Excursion in the Seated Position.
- Author
-
Yamada T, Minami T, Yoshino S, Emoto K, Mabuchi S, Hanazawa R, Hirakawa A, and Hashimoto M
- Subjects
- Humans, Reference Values, Ultrasonography, Respiration, Diaphragm diagnostic imaging, Sitting Position
- Abstract
Introduction: Measurements of diaphragm function by ultrasonography are affected by body position, but reference values in the seated position have not been established for an Asian population. This study aimed to determine reference values for diaphragm thickness, thickening fraction, and dome excursion by ultrasonography and to investigate the effects of sex, height, and body mass index., Methods: Diaphragm ultrasonography was performed on 109 seated Japanese volunteers with normal respiratory function who were enrolled between March 2022 and January 2023. Thickness, thickening fraction, and excursion were measured. Reference values and the measurement success rate were calculated. Multivariate analysis adjusted for sex, height, and body mass index was performed., Results: The measurement success rate was better for thickness than for excursion. The mean (lower limit of normal) values on the right/left sides were as follows. During quiet breathing, thickness at end expiration(mm) was 1.7 (0.9)/1.6 (0.80), thickening fraction(%) was 50 (0.0)/52 (0.0), and excursion(cm) was 1.7 (0.5)/1.9 (0.5). During deep breathing, the thickening fraction was 111 (24)/107 (22), and the excursion was 4.4 (1.7)/4.1 (2.0). In multivariate analysis, body mass index was positively associated with thickness but not with the thickening fraction., Conclusion: The reference values in this study were smaller than those in previous reports from Europe. Considering that thickness is influenced by body mass index, using Western reference values in Asia, where the average body mass index is lower, might not be appropriate. The thickening fraction in deep breathing is unaffected by other items and can be used more universally., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
65. Sphincter of Oddi dysfunction that could not be diagnosed with Rome IV: a case report.
- Author
-
Hashido N, Kobayashi M, Kawamoto A, Mabuchi S, Katsuda H, Ohtsuka K, Asahina Y, Hashimoto M, and Okamoto R
- Subjects
- Female, Humans, Adult, Rome, Sphincterotomy, Endoscopic, Cholangiopancreatography, Endoscopic Retrograde, Abdominal Pain etiology, Manometry, Sphincter of Oddi, Sphincter of Oddi Dysfunction diagnosis, Sphincter of Oddi Dysfunction diagnostic imaging
- Abstract
A 30-year-old female patient presented with monthly episodes of severe intermittent upper abdominal pain, especially after consuming fatty meals. Over a period of 5 years, she visited the emergency department 21 times due to the intensity of the pain. Although the pain appeared consistent with biliary pain, both blood and imaging tests showed no abnormalities. Despite not meeting the Rome IV criteria, we suspected sphincter of Oddi dysfunction (SOD). To further investigate, we conducted hepatobiliary scintigraphy (HBS), which revealed a clear delay in bile excretion. With the patient's informed consent, we performed endoscopic sphincterotomy (EST) and as of 10 months later, there have been no recurrences. This case demonstrates an instance of SOD that could not be diagnosed using the Rome IV criteria alone but was successfully identified through HBS. It underscores the possibility of hidden cases of SOD among patients who regularly experience severe epigastric pain, where routine blood or imaging tests may not provide a diagnosis. HBS may be a useful non-invasive test in confirming the presence of previously undiagnosed SOD. As SOD can be easily treated with EST, updating the current diagnostic criteria to include such types of SOD should be considered in the future., (© 2023. Japanese Society of Gastroenterology.)
- Published
- 2023
- Full Text
- View/download PDF
66. Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data.
- Author
-
Komura N, Mabuchi S, Sasano T, Kamiura S, Morishima T, and Miyashiro I
- Abstract
Objective: To assess the mortality trends of four major histological subtypes of cervical cancer diagnosed between 1994 and 2018., Methods: This population-based retrospective cohort study was conducted using the Osaka Cancer Registry data from 1994 to 2018. A total of 12,003 patients with cervical cancer, squamous cell carcinoma (SCC), adenocarcinoma (A), adenosquamous cell carcinoma (AS), or small cell neuroendocrine carcinoma (SCNEC) were identified. Patients were classified into groups according to the extent of disease (localized, regional, or distant), year of diagnosis (1994-2002, 2003-2010, or 2011-2018), and histological subtype (SCC, A/AS, or SCNEC). Then, their survival rates were assessed using univariate and multivariate analyses., Results: Overall, improved survival rates were observed according to the year of diagnosis in patients with local, regional, and distant cervical cancers. When examined according to the histological subtypes, improved survival rates according to the year of diagnosis were observed in patients with local, regional, and distant SCCs and in those with local and regional A/AS. In patients with distant A/AS, the survival rates did not improve since 2003. In patients with cervical cancer with SCNEC, the survival rates did not improve since 1994 irrespective of the extent of the disease. In the multivariate analysis, non-SCC histology was found to be an independent prognostic factor for OS., Conclusion: In contrast to SCC histology associated with improved survival between 1994 and 2018, SCNEC histology and advanced (stage IVB) A/AS remain to be the unmet medical needs for the management of cervical cancer., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Komura, Mabuchi, Sasano, Kamiura, Morishima and Miyashiro.)
- Published
- 2023
- Full Text
- View/download PDF
67. Development of a national point-of-care ultrasound training course for physicians in Japan: A 3-year evaluation.
- Author
-
Yamada T, Minami T, Kitano Y, Yoshino S, Mabuchi S, and Soni NJ
- Abstract
Purpose : Point-of-care ultrasound (POCUS) allows bedside clinicians to acquire, interpret, and integrate ultrasound images into patient care. Although the availability of POCUS training courses has increased, the educational effectiveness of these courses is unclear. Methods : From 2017 to 2019, we investigated the educational effectiveness of a standardized 2-day hands-on POCUS training course and changes in pre- and post-course exam scores in relationship to participants' (n = 571) clinical rank, years of POCUS experience, and frequency of POCUS use in clinical practice. Results : The mean pre- and post-course examination scores were 67.2 (standard deviation [SD] 12.3) and 79.7 (SD 9.7), respectively. Higher pre-course examination scores were associated with higher clinical rank, more years of POCUS experience, and more frequent POCUS use (p < 0.05). All participants showed significant changes in pre- to post-course exam scores. Though pre-course scores differed by clinical rank, POCUS experience, and frequency of POCUS use, differences in post-course scores according to participant baseline differences were non-significant. Conclusion : A standardized hands-on POCUS training course is effective for improving POCUS knowledge regardless of baseline differences in clinical rank, POCUS experience, or frequency of POCUS use. Future studies shall evaluate changes in POCUS use in clinical practice after POCUS training., Competing Interests: Competing interests: Taro Minami is a consultant to FUJIFILM Corporation, Japan, for a project funded by the Ministry of Economy, Trade, and Industry, Japan., (Copyright: © 2023 Yamada T et al.)
- Published
- 2023
- Full Text
- View/download PDF
68. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
- Author
-
Mabuchi S, Komura N, Sasano T, Sakata M, Matsuzaki S, Hisa T, Kamiura S, Morishima T, and Miyashiro I
- Subjects
- Female, Humans, Retrospective Studies, Neoplasm Staging, Survival Analysis, Uterine Cervical Neoplasms therapy, Uterine Cervical Neoplasms pathology, Carcinoma, Small Cell therapy, Carcinoma, Squamous Cell pathology, Carcinoma, Neuroendocrine therapy, Carcinoma, Neuroendocrine pathology
- Abstract
The aim of the current study is to investigate the survival outcome of stage IVB SCNEC of the uterine cervix in comparison to major histological subtypes of cervical cancer. A population-based retrospective cohort study was conducted using the Osaka Cancer Registry data from 1994 to 2018. All FIGO 2009 stage IVB cervical cancer patients who displayed squamous cell carcinoma (SCC), adenocarcinoma (A), adenosquamous cell carcinoma (AS), or small-cell neuroendocrine carcinoma (SCNEC) were first identified. The patients were classified into groups according to the types of primary treatment. Then, their survival rates were examined using the Kaplan-Meier method. Overall, in a total of 1158 patients, clearly differential survival rates were observed according to the histological subtypes, and SCNEC was associated with shortest survival. When examined according to the types of primary treatments, SCNEC was associated with significantly decreased survival when compared to SCC or A/AS, except for those treated with surgery. In patients with FIGO 2009 stage IVB cervical cancer, SCNEC was associated with decreased survival when compared to SCC or A/AS. Although current treatments with either surgery, chemotherapy or radiotherapy have some therapeutic efficacies, to improve the prognosis, novel effective treatments specifically targeting cervical SCNEC need to be developed.
- Published
- 2023
- Full Text
- View/download PDF
69. Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian Germ Cell Tumors.
- Author
-
Sakaguchi-Mukaida H, Matsuzaki S, Ueda Y, Matsuzaki S, Kakuda M, Lee M, Deguchi S, Sakata M, Maeda M, Kakubari R, Hisa T, Mabuchi S, and Kamiura S
- Abstract
Randomized clinical trials assessing the efficacy of neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer have predominantly included women with high-grade serous carcinomas. The response rate and oncological outcomes of NACT for malignant ovarian germ cell tumors (MOGCT) are poorly understood. This study aimed to examine the effects of NACT on women with MOGCT by conducting a systematic review of four public search engines. Fifteen studies were identified, and a further descriptive analysis was performed for 10 original articles. In those studies, most women were treated with a bleomycin, etoposide, and cisplatin regimen, and one to three cycles were used in most studies. Four studies comparing NACT and primary debulking surgery showed similar complete response rates ( n = 2; pooled odds ratio [OR] 0.90, 95% confidence interval [CI] 0.15-5.27), comparable overall survival ( n = 3; 87.0-100% versus 70.0-100%), disease-free survival ( n = 3; 87.0-100% versus 70.0-100%), recurrence rate ( n = 1; OR 3.50, 95%CI 0.38-32.50), and adverse events rate from chemotherapy between the groups. In conclusion, NACT may be considered for the management of MOGCT; however, possible candidates for NACT use and an ideal number of NACT cycles remain unknown. Further studies are warranted to validate the efficacy of NACT in advanced MOGCT patients.
- Published
- 2023
- Full Text
- View/download PDF
70. FD-2, an Anticervical Stenosis Device for Patients Undergoing Radical Trachelectomy or Cervical Conization.
- Author
-
Mabuchi S, Kamiura S, Saito T, Furukawa H, Abe A, and Sasagawa T
- Abstract
This study aimed to introduce FD-2, a newly developed anticervical stenosis device for patients with cervical cancer undergoing radical trachelectomy. Using ethylene-vinyl acetate copolymers, we developed FD-2 to prevent uterine cervical stenosis after radical trachelectomy. The tensile test and extractables and leachables testing were performed to evaluate FD-2's safety as a medical device. FD-2 was indwelled in three patients with cervical cancer during radical trachelectomy and its utility was preliminarily evaluated. FD-2 consists of a head (fish-born-like structure), neck (connecting bridges), and body (tubular structure); the head is identical to FD-1, an intrauterine contraceptive device. FD-2 passed the tensile test and extractables and leachables testing. The average time required for the application or removal of FD-2 in cervical cancer patients was less than 10 s. The median duration of FD-2 indwelling was 8 weeks. No complications, including abdominal pain, pelvic infections, or hemorrhages, associated with FD-2 indwelling were reported. At the 3-12-month follow-up after the radical trachelectomy, no patients developed cervical stenosis or experienced dysmenorrhea. In conclusion, we developed FD-2, a novel device that can be used for preventing cervical stenosis after radical trachelectomy for uterine cervical cancer.
- Published
- 2023
- Full Text
- View/download PDF
71. Evaluation of survival outcomes between minimally invasive and open surgery in the treatment of early-stage endometrial cancer: a population-based study in Osaka Japan.
- Author
-
Sasano T, Mabuchi S, Komura N, Maeda M, Kamiura S, Morishima T, and Miyashiro I
- Subjects
- Humans, Female, Retrospective Studies, Neoplasm Staging, Japan epidemiology, Minimally Invasive Surgical Procedures, Hysterectomy, Endometrial Neoplasms pathology, Robotic Surgical Procedures
- Abstract
Objective: To compare the oncological outcomes between Japanese women who underwent minimally invasive surgery and those who underwent open surgery for early-stage endometrial cancer., Methods: This population-based retrospective cohort study was conducted using data from the Osaka Cancer Registry from 2011 to 2018. Surgically treated patients for localized (uterine-confined) endometrial cancer were identified. Patients were classified into two groups according to the type of surgery (minimally invasive surgery group and open-surgery group), pathological risk factors (low-risk and high-risk), and year of diagnosis (Group 1, 2011-14; Group 2, 2015-18). Overall survival was compared between the minimally invasive surgery and open-surgery groups., Results: In the analyses including all patients, there was no difference in overall survival between the minimally invasive surgery and open-surgery groups (P = 0.0797). The 4-year overall survival rate was 97.1 and 95.7% in the minimally invasive surgery and open-surgery groups, respectively. When investigated according to pathological risks, there were no differences in overall survival between the minimally invasive surgery and open-surgery groups in both the low- and high-risk groups. In the low-risk group, the 4-year overall survival rates in the minimally invasive surgery and open-surgery groups were 97.7 and 96.5%, respectively. In the high-risk group, the 4-year overall survival rates in the minimally invasive surgery and open-surgery groups were 91.2 and 93.2%, respectively. Similarly, there were no differences in overall survival between the minimally invasive surgery and open-surgery groups in both Group 1 (P = 0.4479 in low-risk and P = 0.1826 in high-risk groups) and Group 2 (P = 0.1750 in low-risk and P = 0.0799 in high-risk groups)., Conclusion: Our study provides epidemiological evidence that minimally invasive surgery is an effective alternative to open surgery in Japanese patients with early-stage endometrial cancer., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
72. Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy.
- Author
-
Sugimoto A, Watanabe T, Matsuoka K, Okuno Y, Yanagi Y, Narita Y, Mabuchi S, Nobusue H, Sugihara E, Hirayama M, Ide T, Onouchi T, Sato Y, Kanda T, Saya H, Iwatani Y, Kimura H, and Murata T
- Subjects
- Humans, Herpesvirus 4, Human genetics, Epstein-Barr Virus Nuclear Antigens genetics, Epstein-Barr Virus Nuclear Antigens metabolism, Viral Proteins genetics, Hypertrophy, IMP Dehydrogenase, Epstein-Barr Virus Infections genetics, Lymphoproliferative Disorders
- Abstract
The in vitro growth transformation of primary B cells by Epstein-Barr virus (EBV) is the initial step in the development of posttransplant lymphoproliferative disorder (PTLD). We performed electron microscopic analysis and immunostaining of primary B cells infected with wild-type EBV. Interestingly, the nucleolar size was increased by two days after infection. A recent study found that nucleolar hypertrophy, which is caused by the induction of the IMPDH2 gene, is required for the efficient promotion of growth in cancers. In the present study, RNA-seq revealed that the IMPDH2 gene was significantly induced by EBV and that its level peaked at day 2. Even without EBV infection, the activation of primary B cells by the CD40 ligand and interleukin-4 increased IMPDH2 expression and nucleolar hypertrophy. Using EBNA2 or LMP1 knockout viruses, we found that EBNA2 and MYC , but not LMP1 , induced the IMPDH2 gene during primary infections. IMPDH2 inhibition by mycophenolic acid (MPA) blocked the growth transformation of primary B cells by EBV, leading to smaller nucleoli, nuclei, and cells. Mycophenolate mofetil (MMF), which is a prodrug of MPA that is approved for use as an immunosuppressant, was tested in a mouse xenograft model. Oral MMF significantly improved the survival of mice and reduced splenomegaly. Taken together, these results indicate that EBV induces IMPDH2 expression through EBNA2 -dependent and MYC -dependent mechanisms, leading to the hypertrophy of the nucleoli, nuclei, and cells as well as efficient cell proliferation. Our results provide basic evidence that IMPDH2 induction and nucleolar enlargement are crucial for B cell transformation by EBV. In addition, the use of MMF suppresses PTLD. IMPORTANCE EBV infections cause nucleolar enlargement via the induction of IMPDH2, which are essential for B cell growth transformation by EBV. Although the significance of IMPDH2 induction and nuclear hypertrophy in the tumorigenesis of glioblastoma has been reported, EBV infection brings about the change quickly by using its transcriptional cofactor, EBNA2, and MYC. Moreover, we present here, for the novel, basic evidence that an IMPDH2 inhibitor, namely, MPA or MMF, can be used for EBV-positive posttransplant lymphoproliferative disorder (PTLD)., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
73. Relationship between Abnormal Placenta and Obstetric Outcomes: A Meta-Analysis.
- Author
-
Matsuzaki S, Ueda Y, Matsuzaki S, Sakaguchi H, Kakuda M, Lee M, Takemoto Y, Hayashida H, Maeda M, Kakubari R, Hisa T, Mabuchi S, and Kamiura S
- Abstract
The placenta has several crucial physiological functions that help maintain a normal pregnancy. Although approximately 2-4% of pregnancies are complicated by abnormal placentas, obstetric outcomes remain understudied. This study aimed to determine the outcomes and prevalence of patients with abnormal placentas by conducting a systematic review of 48 studies published between 1974 and 2022. The cumulative prevalence of circumvallate placenta, succenturiate placenta, multilobed placenta, and placenta membranacea were 1.2%, 1.0%, 0.2%, and 0.004%, respectively. Pregnancies with a circumvallate placenta were associated with an increased rate of emergent cesarean delivery, preterm birth (PTB), and placental abruption compared to those without a circumvallate placenta. The succenturiate lobe of the placenta was associated with a higher rate of emergent cesarean delivery, whereas comparative results were observed in terms of PTB, placental abruption, and placenta previa in comparison to those without a succenturiate lobe of the placenta. A comparator study that examined the outcomes of multilobed placentas found that this data is usually unavailable. Patient-level analysis ( n = 15) showed high-rates of abortion (40%), placenta accreta spectrum (40%), and a low term delivery rate (13.3%) in women with placenta membranacea. Although the current evidence is insufficient to draw a robust conclusion, abnormal placentas should be recognized as a high-risk factor for adverse outcomes during pregnancy.
- Published
- 2023
- Full Text
- View/download PDF
74. Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study.
- Author
-
Mabuchi S, Sasano T, Komura N, Maeda M, Matsuzaki S, Hisa T, Kamiura S, Morishima T, and Miyashiro I
- Abstract
We aimed to compare the oncological outcomes between Japanese women with uterine-confined and node-negative cervical cancer who underwent open surgery and those who underwent minimally invasive surgery (MIS). A population-based retrospective cohort study was conducted using data from the Osaka Cancer Registry that ranged from 2011 to 2018. A total of 2279 patients who underwent surgical treatment for uterine-confined and node-negative cervical cancer were identified. The patients were classified into groups according to surgery type (open and MIS groups) and year of diagnosis (group one, 2011-2014; group two, 2015-2018). The oncologic outcomes were compared between the MIS and open groups. When the MIS group (n = 225) was compared with open group (n = 2054), overall, there was no significant between-group difference in terms of overall survival. Based on Kaplan-Meier estimates, the probability of overall survival at four years was 99.5% in the MIS group and 97.2% in the open group ( p = 0.1110). When examined according to the year of diagnosis, there were no significant between-group differences in the overall survival in both groups one and two. In this population-based cohort study, MIS did not compromise survival outcomes when compared with conventional open surgery in Japanese patients with uterine-confined and node-negative (FIGO 2018 stage I) cervical cancer.
- Published
- 2023
- Full Text
- View/download PDF
75. Bone-targeting polyphosphodiesters that promote osteoblastic differentiation.
- Author
-
Kiyono K, Mabuchi S, Otaka A, and Iwasaki Y
- Subjects
- Animals, Mice, Tissue Distribution, Cell Differentiation, Osteoblasts, Signal Transduction, Bone and Bones metabolism
- Abstract
Polymers for pharmaceutical use have been attractive in medical treatments because of the conjugation of multifunctional components and their long circulation time in the blood stream. Bone-targeted drug delivery systems are also no exceptional, and several polymers have been proposed for the treatment of bone diseases, such as cancer metastasis and osteoporosis. Herein, we report that polyphosphodiesters (PPDEs) have a potential to enhance osteoblastic differentiation, and they have a targeting ability to bone tissues in vivo. Two types of PPDEs, poly (ethylene sodium phosphate) (PEP•Na) and poly (propylene sodium phosphate) (PPP•Na), have been synthesized. Regardless of the alkylene structure in the main chain of PPDEs, the gene expression of osteoblast-specific transcription factors and differentiation markers of mouse osteoblastic-like cells (MC3T3-E1 cells) cultured in a differentiation medium was significantly upregulated by the addition of PPDEs. Moreover, it was also clarified that the signaling pathway related to cytoplasmic calcium ions was activated by PPDEs. The mineralization of MC3T3-E1 cells has a similar trend with its gene expression and is synergistically enhanced by PPDEs with β-glycerophosphate. The biodistribution of fluorescence-labeled PPDEs was also determined after intravenous injection in mice. PPDEs accumulated well in the bone through the blood stream, whereas polyphosphotriesters (PPTEs) tended to be excreted from the kidneys. Hydrophilic PEP•Na showed a superior bone affinity as compared with PPP•Na. PPDEs could be candidate polymers for the restoration of bone remodeling and bone-targeting drug delivery platforms., (© 2023 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
76. [Safety and Efficacy of Robot-Assisted Surgery for Early Uterine Cancer in Our Institution over Five Years Since Its Introduction].
- Author
-
Kitada F, Matsumoto Y, Umemoto M, Atsumi R, Okura R, Suginami N, Ikeuchi R, Miyazaki A, Watanabe A, and Mabuchi S
- Subjects
- Humans, Female, Treatment Outcome, Robotic Surgical Procedures, Genital Neoplasms, Female, Uterine Neoplasms surgery, Laparoscopy
- Abstract
Lacking experience of laparoscopic surgery against gynecologic malignancies, we started performing robot-assisted surgery for uterine cancer in September 2017. Here we compared the safety and efficacy of robot-assisted surgery with those of open surgery in early-stage uterine cancer patients. The surgical time was significantly longer and the blood loss and hospital stay were significantly shorter for robot-assisted versus open surgery. No recurrence was observed after robot-assisted surgery. Robot-assisted surgery can be safely performed even in general hospitals and is an effective treatment option for early-stage uterine cancer patients.
- Published
- 2023
77. Impact of lymphadenectomy in patients with locally recurrent or persistent cervical cancer treated with salvage hysterectomy.
- Author
-
Mabuchi S, Komura N, Kodama M, Matsuzaki S, Matsumoto Y, Kamiura S, and Kimura T
- Subjects
- Female, Humans, Lymphatic Metastasis pathology, Lymph Node Excision methods, Lymph Nodes surgery, Lymph Nodes pathology, Hysterectomy, Postoperative Complications etiology, Neoplasm Staging, Retrospective Studies, Uterine Cervical Neoplasms pathology
- Abstract
Aim: To investigate the role of lymphadenectomy (LND) in locally recurrent or persistent cervical cancer patients treated with salvage hysterectomy., Methods: Locally recurrent or persistent cervical cancer patients treated with salvage hysterectomy, with or without LND, were identified. Patients were divided into two groups according to the status of radiologic evidence of lymph node metastasis, and the impact of LND was investigated by evaluating postoperative survival., Results: This study included 72 patients; 48 did not show radiological evidence of lymph node metastasis (Group 1) while 24 did (Group 2). Overall, the addition of LND to salvage hysterectomy resulted in increased postoperative complications. In Group 1, salvage hysterectomy plus LND resulted in the identification of five cases with false-negative lymph nodes (19.2%), but showed no advantage over salvage hysterectomy alone in terms of postoperative survival. In Group 2, all patients underwent LND, which resulted in the identification of eight cases with false-positive nodes (33.3%), and reasonably long postoperative survival. The estimated 3-year postoperative survival rate in this group was 39.7%., Conclusion: Including LND in salvage hysterectomy allows for precise lymph node staging but increases risk of postoperative complications. However, considering the inability to improve survival, LND should not be performed during salvage hysterectomy in patients without radiological evidence of lymph node metastasis. In patients with radiological evidence of lymph node metastasis, salvage hysterectomy plus LND can only be performed in those who understand the risk of postoperative complications and the limited evidence supporting its survival advantage., (© 2022 Japan Society of Obstetrics and Gynecology.)
- Published
- 2023
- Full Text
- View/download PDF
78. Spontaneous bladder rupture attributable to a radical hysterectomy-associated neurogenic bladder in patients with cervical cancer: A case report and literature review.
- Author
-
Hayashida H, Mabuchi S, Kawamura N, Matsuzaki S, Hisa T, and Kamiura S
- Abstract
Introduction and Importance: Spontaneous bladder rupture (SBR) is an extremely rare urological emergency. Herein we report a rare case of SBR in a postoperative cervical cancer patient, which was attributable to bladder distension due to a radical hysterectomy-associated neurogenic bladder., Case Presentation: A 74-year-old nulliparous Japanese patient with cervical cancer (pT1b3N0M0) presented with acute abdominal pain nine days after a radical hysterectomy. The pretreatment workup included plain computed tomography (CT) revealed the presence of ascites in the absence of gastrointestinal perforation. The patient was initially diagnosed with generalized bacterial peritonitis and treated with antibiotics. Urine outflow was noted 5 days later from the vaginal stump. Subsequent contrast-enhanced CT demonstrated a bladder wall defect with presence of contrast medium in the abdominal cavity. The patient was diagnosed with SBR and was conservatively treated with antibiotics and prolonged catheterization (4 weeks); these measures showed no signs of therapeutic efficacy. The patient was subsequently treated surgically with an ileal conduit urinary diversion. The patient is currently free of disease., Clinical Discussion: A literature review revealed that a history of pelvic radiotherapy is the main predisposing factor for SBR in women with cervical cancer. Our case serves to alert physicians that SBR should be considered a differential diagnosis in postoperative cervical cancer patients without a history of pelvic radiotherapy who experience generalized peritonitis symptoms or present as an acute abdomen., Conclusion: SBR can develop in cervical cancer patients without a history of radiotherapy. This differential diagnosis should be considered in patients with a radical hysterectomy-associated neurogenic bladder., Competing Interests: Declaration of competing interest Not applicable., (Copyright © 2023. Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
79. [Reduction in Patient Waiting Times in Pharmacies by a Protocol to Minimize Inquiries to Doctors under an Agreement between a Hospital and Community Pharmacies].
- Author
-
Hiramatsu H, Kobayashi R, Fujii H, Uno M, Masuda C, Mabuchi S, Hirashita T, Hayashi T, Iguchi K, Teramachi H, Ibuka H, Ohashi T, Suzuki A, and Yasuda K
- Subjects
- Humans, Waiting Lists, Hospitals, Pharmacies, Pharmacy, Physicians
- Abstract
Cooperative care between hospitals and community pharmacies is important to safe and effective pharmacotherapy for outpatients. We developed a protocol comprising three agreements about alternative drugs and dosing schedules with the aim of minimizing inquiries about prescriptions to doctors. The protocol was implemented under an agreement between core hospitals in Gifu City and community pharmacy members of the Gifu City Pharmaceutical Association from October 2019. Here, we examined the impact of this protocol on patient waiting time in pharmacies. Before introduction of the protocol, median patient waiting time for questionable prescriptions requiring an inquiry to a doctor was significantly longer than that for prescriptions not requiring an inquiry (23.0 min vs. 10.0 min, p<0.001). After introduction of the protocol, median time for prescriptions which were questionable but nevertheless under the protocol did not require an inquiry to a doctor was significantly reduced compared with those which were questionable and still did require an inquiry (15.0 min vs. 24.0 min, p=0.038). In conclusion, introduction of a protocol aimed at minimizing inquiries about prescriptions to doctors from a community pharmacy was useful in reducing the waiting time of patients, and also likely in decreasing the working times of medical doctors and pharmacists.
- Published
- 2023
- Full Text
- View/download PDF
80. Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy.
- Author
-
Kuruma A, Kodama M, Hori Y, Sato K, Fujii M, Isohashi F, Miyoshi A, Mabuchi S, Setoguchi A, Shimura H, Goto T, Toda A, Nakagawa S, Kinose Y, Takiuchi T, Kobayashi E, Hashimoto K, Ueda Y, Sawada K, Morii E, and Kimura T
- Abstract
We aimed to evaluate the response to definitive radiotherapy (RT) for cervical cancer based on histological subtypes and investigate prognostic factors in adenocarcinoma (AC). Of the 396 patients treated with definitive RT between January, 2010 and July, 2020, 327 patients met the inclusion criteria, including 275 with squamous cell carcinoma (SCC) and 52 with AC restaged based on the 2018 International Federation of Gynecology and Obstetrics staging system. Patient characteristics, response to RT, and prognoses of SCC and AC were evaluated. The complete response (CR) rates were 92.4% and 53.8% for SCC and AC, respectively (p < 0.05). Three-year overall survival and progression-free survival (PFS) rates of SCC were significantly higher than those of AC (88.6% vs. 74.1%, p < 0.05 and 76.3% vs. 59.3%, p < 0.05, respectively). Among the AC population, univariate and multivariate analyses were performed to examine prognostic factors associated with non-complete response (CR). In the multivariate analysis, gastric-type adenocarcinoma (GAS) was associated with non-CR in AC (adjusted odds ratio, 12.2; 95% confidence interval 1.0−145.6; p < 0.05). The 3-year PFS rate in patients with GAS was significantly lower than that in patients with other histological types of AC (44.4% vs. 66.7%, p < 0.05). Definitive RT for cervical cancer was significantly less effective for AC than for SCC. GAS was the only independent prognostic factor associated with non-CR in AC.
- Published
- 2022
- Full Text
- View/download PDF
81. The Characteristics and Obstetric Outcomes of Type II Vasa Previa: Systematic Review and Meta-Analysis.
- Author
-
Matsuzaki S, Ueda Y, Matsuzaki S, Kakuda M, Lee M, Takemoto Y, Hayashida H, Maeda M, Kakubari R, Hisa T, Mabuchi S, and Kamiura S
- Abstract
Vasa previa is a rare fetal life-threatening obstetric disease classified into types I and II. This study aimed to examine the characteristics and obstetric outcomes of type II vasa previa. A systematic review was performed, and 20 studies (1998-2022) were identified. The results from six studies showed that type II vasa previa accounted for 21.3% of vasa previa cases. The characteristics and obstetric outcomes (rate of assisted reproductive technology (ART), antenatal diagnosis, emergent cesarean delivery, maternal transfusion, gestational age at delivery, and neonatal mortality) were compared between type I and II vasa previa, and all outcomes of interest were similar. The association between ART and abnormal placenta (bilobed placenta or succenturiate lobe) was examined in three studies, and the results were as follows: ( i ) increased rate of succenturiate lobes (ART versus non-ART pregnancy; OR (odds ratio) 6.97, 95% confidence interval (CI) 2.45-19.78); ( ii ) similar rate of abnormal placenta (cleavage-stage versus blastocyst embryo transfer); ( iii ) increased rate of abnormal placenta (frozen versus fresh embryo transfer; OR 2.97, 95%CI 1.10-7.96). Although the outcomes of type II vasa previa appear to be similar to those of type I vasa previa, the current evidence is insufficient for a robust conclusion.
- Published
- 2022
- Full Text
- View/download PDF
82. Gastric emphysema after percutaneous endoscopic gastrostomy placement.
- Author
-
Mabuchi S, Mabuchi H, and Watari T
- Subjects
- Male, Humans, Aged, 80 and over, Gastrostomy adverse effects, Emphysema diagnostic imaging, Emphysema etiology, Gastritis diagnosis, Gastritis etiology, Gastritis therapy, Intraabdominal Infections
- Abstract
Emphysematous gastritis and gastric emphysema are different diseases. Sometimes, we treat the diseases without distinguishing them clearly because both are rare, and the mortality rate of emphysematous gastritis cases is high (55%). Gastric emphysema is more well known than is emphysematous gastritis after percutaneous endoscopic gastrostomy (PEG) placement (80%). Particularly, it is a self-healing disease, and treatment with antibiotics is not required. CT is commonly used to diagnose emphysematous gastritis and gastric emphysema. The amount of radiation exposure is a concern for performing multiple CTs following air disappearance in the gastric wall. Here, we report the case of a 92-year-old man with gastric emphysema after PEG. It was useful to follow-up the patient by performing radiographic examination, and the disease was managed conservatively without antibiotic administration. We report that distinguishing gastric emphysema from emphysematous gastritis was necessary. Moreover, performance excessive tests and treatments should be avoided., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
83. Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience.
- Author
-
Maeda M, Hisa T, Kurahashi H, Hayashida H, Lee M, Kakubari R, Matsuzaki S, Mabuchi S, and Kamiura S
- Subjects
- Humans, Female, Middle Aged, Hysterectomy, Pelvis, Uterine Cervical Neoplasms surgery, Uterine Cervical Neoplasms pathology, Ovarian Neoplasms surgery
- Abstract
In early-stage cervical cancer, ovarian metastasis is relatively rare, and ovarian transposition is often performed during surgery. Although rare, the diagnosis and surgical approach for recurrence at transposed ovaries are challenging. This study focused on the diagnosis and surgical management of transposed ovarian recurrence in cervical cancer patients. A 45-year-old premenopausal woman underwent radical hysterectomy, bilateral salpingectomy, and pelvic lymphadenectomy following postoperative concurrent chemoradiotherapy for stage IB1 cervical cancer. During the initial surgery, the ovary was transposed to the paracolic gutter, and no postoperative complications were observed. Ovarian recurrence was diagnosed using positron emission tomography-computed tomography, and a laparoscopic bilateral oophorectomy was performed. A systematic review identified nine women with transposed ovarian recurrence with no other metastases of cervical cancer, and no studies have discussed the optimal surveillance of transposed ovaries. Of those (n = 9), four women had died of the disease within 2 years of the second surgery, and the prognosis of transposed ovarian cervical cancer seemed poor. Nevertheless, three women underwent laparoscopic oophorectomies, none of whom experienced recurrence after the second surgery. Few studies have examined the surgical management of transposed ovarian recurrence. The optimal surgical approach for transposed ovarian recurrence of cervical cancer requires further investigation.
- Published
- 2022
- Full Text
- View/download PDF
84. An investigation of the relationship between the performance and management practices of health facilities under a performance-based financing scheme in Nigeria.
- Author
-
Mabuchi S, Alonge O, Tsugawa Y, and Bennett S
- Subjects
- Health Services, Health Surveys, Humans, Nigeria, Health Facilities, Reimbursement, Incentive
- Abstract
Whereas the effect of performance-based financing (PBF) on improving the quantity and quality of health services has been established, little is known about what matters for health facilities to improve performance under a PBF scheme. This study examined the associations between management practices and the performance of primary healthcare centres (PHCCs) under a PBF scheme in Nigeria. This study utilized longitudinal data on monthly institutional deliveries and outpatient visits collected between December 2011 and March 2016 from 111 randomly selected PHCCs in Adamawa, Ondo and Nasarawa states of Nigeria. A management practices scorecard, based on a health facility survey conducted in April/May 2016, was used to derive management practices scores for the 111 PHCCs. The management practices examined included activities to recruit and retain clients, staff's attention to performance targets, listening and responding to client feedback, teamwork building and addressing low-performing staff. A multilevel, multilinear regression model was used to investigate the associations between health facility performance (monthly number of institutional deliveries and outpatient visits) and management practices at the PHCCs, adjusting for key control variables (number of skilled health workers, the size of PHCC catchment population, PHCC quality score, seasonality and states). Following PBF introduction, PHCCs with medium management scores had 0.42 (95% CI 0.18-0.65; P < 0.001) and 9.93 (95% CI 6.15-13.71; P < 0.001) higher monthly improvement rates for institutional delivery and outpatient visits, respectively, compared to the PHCCs with low management scores. Also, the PHCCs with high management scores had 0.49 (95% CI 0.28-0.70; P < 0.001) and 5.10 (95% CI 1.76-8.44; P < 0.003) higher monthly improvement rates for institutional delivery and outpatient visits compared to the PHCCs with low management scores. These findings suggest the importance of management practices in facilitating the effect of PBF on health facility performance and the need to strengthen PHCC management practices in low- and middle-income countries., (© The Author(s) 2022. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
85. Herlyn-Werner-Wunderlich syndrome (HWWS)-associated gynecological malignancies: A case report and literature review.
- Author
-
Mabuchi S, Hayashida H, Kubo C, Takemura M, and Kamiura S
- Abstract
Herlyn-Werner-Wunderlich syndrome (HWWS) is a rare congenital urogenital anomaly characterized by uterine didelphys, unilateral blind hemivagina, and ipsilateral renal agenesis. We present a very rare case of HWWS-associated cervical cancer in which the presence of a genital anomaly was not noticed until the patient experienced postmenopausal vaginal bleeding. A 74-year-old nulliparous Japanese woman presented with vaginal bleeding. Pre-treatment workup revealed uterine didelphys, obstructed hemivagina/hemicervix, renal agenesis, and cancer development from the remnant-obstructed hemivagina/hemicervix. The patient was diagnosed with HWWS and HWWS-associated vaginal or cervical cancer, treated with radical surgery, and a diagnosis of clear cell carcinoma (CCC) of the uterine cervix was histopathologically confirmed. A literature review revealed an increased incidence of CCC in women with HWWS., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
86. Assisted Reproductive Technique and Abnormal Cord Insertion: A Systematic Review and Meta-Analysis.
- Author
-
Matsuzaki S, Ueda Y, Matsuzaki S, Nagase Y, Kakuda M, Lee M, Maeda M, Kurahashi H, Hayashida H, Hisa T, Mabuchi S, and Kamiura S
- Abstract
Abnormal cord insertion (ACI) is associated with adverse obstetric outcomes; however, the relationship between ACI and assisted reproductive technology (ART) has not been examined in a meta-analysis. This study examines the association between ACI and ART, and delivery outcomes of women with ACI. A systematic review was conducted, and 16 studies (1990-2021) met the inclusion criteria. In the unadjusted pooled analysis ( n = 10), ART was correlated with a higher rate of velamentous cord insertion (VCI) (odds ratio (OR) 2.14, 95% confidence interval (CI) 1.64-2.79), marginal cord insertion ( n = 6; OR 1.58, 95%CI 1.26-1.99), and vasa previa ( n = 1; OR 10.96, 95%CI 2.94-40.89). Nevertheless, the VCI rate was similar among the different ART types (blastocyst versus cleavage-stage transfer and frozen v ersus fresh embryo transfer). Regarding the cesarean delivery (CD) rate, women with VCI were more likely to have elective ( n = 3; OR 1.13, 95%CI 1.04-1.22) and emergent CD ( n = 5; OR 1.93, 95%CI 1.82-2.03). In conclusion, ART may be correlated with an increased prevalence of ACI. However, most studies could not exclude confounding factors; thus, further studies are warranted to characterize ART as a risk factor for ACI. In women with ACI, elective and emergent CD rates are high.
- Published
- 2022
- Full Text
- View/download PDF
87. Significance of the Number and the Location of Metastatic Lymph Nodes in Locally Recurrent or Persistent Cervical Cancer Patients Treated with Salvage Hysterectomy plus Lymphadenectomy.
- Author
-
Mabuchi S, Komura N, Kodama M, Maeda M, Matsumoto Y, and Kamiura S
- Subjects
- Female, Humans, Hysterectomy methods, Lymph Node Excision methods, Lymphatic Metastasis, Retrospective Studies, Salvage Therapy, Lymph Nodes pathology, Lymph Nodes surgery, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local surgery, Uterine Cervical Neoplasms pathology, Uterine Cervical Neoplasms surgery
- Abstract
We retrospectively investigated the significance of metastatic lymph nodes in patients with locally recurrent or persistent cervical cancer in a previously irradiated field and subsequently had salvage hysterectomy. Clinical data were obtained from a chart review, and the prognostic impact of the presence, number (1-2 versus ≥3), and location (pelvic versus pelvic plus para-aortic) of lymph node metastasis was investigated by comparing recurrence and survival. In total, 50 patients were included in this study, of which 21 (42.0%) showed pathological evidence of lymph node metastasis (node-positive group). Both the univariate and multivariate analyses showed that lymph node metastasis was an independent prognostic factor for postoperative recurrence (hazard ratio (HR) 5.36; 95% CI 1.41-6.66; p = 0.0020). The predominant sites of recurrence after salvage surgery were the visceral organs and lymph nodes in the node-negative and node-positive groups, respectively. Patients with ≥3 node metastases showed similar survival to those with 1-2 node metastases. Patients with pelvic node metastasis showed similar survival to those with pelvic and para-aortic node metastases. The presence, not number or location, of lymph node metastasis was an independent poor prognostic factor for post-operative recurrence in patients who developed locally recurrent or persistent cervical cancer treated with salvage hysterectomy plus lymphadenectomy.
- Published
- 2022
- Full Text
- View/download PDF
88. The first case of granulocyte colony-stimulating factor producing vulvar cancer.
- Author
-
Kimura M, Uchiyama T, and Mabuchi S
- Subjects
- Aged, Female, Granulocyte Colony-Stimulating Factor, Humans, Leukocyte Count, Vulvar Neoplasms
- Published
- 2022
- Full Text
- View/download PDF
89. Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.
- Author
-
Yagi T, Sawada K, Miyamoto M, Kinose Y, Nakagawa S, Takiuchi T, Kodama M, Kobayashi E, Hashimoto K, Mabuchi S, Tomimatsu T, Yoshino K, and Kimura T
- Subjects
- Anxiety, Dietary Supplements, Drugs, Chinese Herbal, Fatigue drug therapy, Fatigue etiology, Female, Hemoglobins, Humans, Iron therapeutic use, Anemia drug therapy
- Abstract
Background: Preoperative anemia affects perioperative outcomes and often causes fatigue and psychological disorders. Therefore, anemia should be treated before a patient undergoes surgery. Ninjin'yoeito (NYT), a Japanese Kampo medicine composed of ginseng and Japanese angelica root with the other 10 herbs, is administered for anemia, fatigue and anxiety; however, there are a few reports that have prospectively examined the effects of NYT before surgery for gynecological diseases. Hence, we tended to investigate its efficacy and safety., Methods: In this open-label randomized trial, women with gynecological diseases accompanied by preoperative anemia (defined as < 11.0 g/dL Hemoglobin [Hb]) were randomly assigned (1:1) into the iron supplementation and NYT groups. Patients of the iron supplementation group and the NYT group received 100 mg/day iron supplementation with and without NYT (7.5 g/day) for at least 10 days before surgery. The primary endpoint was improvement in Hb levels before and after treatment, and Cancer Fatigue Scale (CFS) and Visual Analogue Scale for Anxiety (VAS-A) scores between groups. Statistical analyses were performed with Wilcoxon signed rank test, Wilcoxon rank sum test, and Fisher's exact test as appropriate., Results: Forty patients were enrolled of whom 30 patients were finally analyzed after allocating 15 to each group. There was no difference in the characteristics between both groups. Hb significantly increased in both groups (iron supplementation group, 9.9 ± 0.8 g/dL vs. 11.9 ± 1.6 g/dL; NYT group, 9.8 ± 1.0 g/dL vs. 12.0 ± 1.0 g/dL); the difference in the elevations in Hb between both groups was statistically insignificant (P = 0.72). Contrarily, CFS (17.9 ± 10.2 vs. 8.1 ± 5.2) and VAS-A (56 mm (50-70) vs. 23 mm (6-48)) scores were significantly decreased only in the NYT group and these changes were greater in the NYT group (∆CFS, P = 0.015; ∆VAS-A, P = 0.014). Liver dysfunction occurred in one patient of the NYT group., Conclusions: For treating preoperative anemia in women with gynecological conditions, NYT administration along with iron supplementation safely and efficiently improved the preoperative fatigue and anxiety in addition to the recovery from anemia., Trial Registration: jRCT1051190012 (28/April/2019, retrospectively registered)., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
90. The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study.
- Author
-
Maeda M, Hisa T, Matsuzaki S, Lee M, Mabuchi S, and Kamiura S
- Subjects
- Adult, Female, Humans, Middle Aged, Retrospective Studies, Laser Therapy methods, Surgeons, Uterine Cervical Neoplasms pathology, Uterine Cervical Dysplasia pathology, Uterine Cervical Dysplasia surgery
- Abstract
Although laser vaporization is a popular minimally invasive treatment for cervical intraepithelial neoplasia (CIN), factors influencing CIN recurrence are understudied. Moreover, the effect of surgeon volume on patients' prognosis after laser vaporization for CIN is unknown. This single-center retrospective study evaluated the predictive value of surgeon volume and patient characteristics for laser vaporization outcomes in women with pathologically confirmed CIN2. Histologically confirmed CIN2 or higher grade after laser vaporization was defined as persistent or recurrent. Various patient characteristics were compared between women with and those without recurrence to examine the predictive factors for laser vaporization. There were 270 patients with a median age of 36 (18-60) years. The median follow-up period was 25 (6-75.5) months and the median period between treatment and persistence or recurrence was 17 (1.5-69) months. The median annual number of procedures for all seven surgeons was 7.8. There were 38 patients (14.1%) with persistent or recurrent lesions-24 had CIN2, 13 had CIN3, and one had adenocarcinoma in situ. Patient age, body mass index, surgeon volume, and history of prior CIN treatment or invasive cervical cancer were not significantly correlated with lesion persistence or recurrence. In conclusion, laser vaporization has comparable success rates and is a feasible treatment for both low- and high-volume surgeons.
- Published
- 2022
- Full Text
- View/download PDF
91. Granulomatous Mastitis With Erythema Nodosum During Pregnancy: A Case Report.
- Author
-
Mabuchi S, Ohta R, Egawa K, Narai Y, and Sano C
- Abstract
Granulomatous mastitis is a rare benign disease that typically occurs in parous women. Some reports have described cases of erythema nodosum appearing following granulomatous mastitis, which is often treated with steroids. Here, we report a case of granulomatous mastitis with erythema nodosum successfully treated via drainage only, which may have been caused by the higher plasma cortisol levels observed during pregnancy. Although mastitis is rare during pregnancy, the current case suggests that granulomatous mastitis should be considered in pregnant women with treatment-resistant mastitis, especially in those with erythema nodosum and a history of birth. Furthermore, patients with granulomatous mastitis may not require prednisolone treatment during pregnancy, which may help in preventing steroid-associated conditions such as infections and gestational diabetes mellitus., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2022, Mabuchi et al.)
- Published
- 2022
- Full Text
- View/download PDF
92. Primary Fallopian Tube Carcinoma Presenting with a Massive Inguinal Tumor: A Case Report and Literature Review.
- Author
-
Maeda M, Hisa T, Matsuzaki S, Ohe S, Nagata S, Lee M, Mabuchi S, and Kamiura S
- Subjects
- Aged, Fallopian Tubes, Female, Humans, Lymphatic Metastasis, Neoplasm Recurrence, Local, Carcinoma, Fallopian Tube Neoplasms complications, Fallopian Tube Neoplasms pathology, Fallopian Tube Neoplasms surgery, Ovarian Neoplasms complications, Ovarian Neoplasms surgery
- Abstract
Primary fallopian tube carcinoma (PFTC) has characteristics similar to those of ovarian carcinoma. The typical course of PFTC metastasis includes peritoneal dissemination and pelvic and paraaortic lymph node metastasis, while inguinal lymph node metastasis is rare. Moreover, the initial presentation of PFTC with an inguinal tumor is extremely rare. A 77-year-old postmenopausal woman presented with a massive 12-cm inguinal subcutaneous tumor. After tumor resection, histopathological and immunohistochemical analysis showed that the tumor was a high-grade serous carcinoma of gynecological origin. Subsequent surgery for total hysterectomy with bilateral salpingo-oophorectomy revealed that the tumor developed in the fallopian tube. She received adjuvant chemotherapy with carboplatin and paclitaxel, followed by maintenance therapy with niraparib. There has been no recurrence or metastasis 9 months after the second surgery. We reviewed the literature for cases of PFTC and ovarian carcinoma that initially presented with an inguinal tumor. In compliance with the Preferred Reporting Items for Systematic Reviews guidelines, a systematic literature search was performed through 31 January 2022 using the PubMed and Google scholar databases and identified 14 cases. In half of them, it was difficult to identify the primary site using preoperative imaging modalities. Disease recurrence occurred in two cases; thus, the prognosis of this type of PFTC appears to be good.
- Published
- 2022
- Full Text
- View/download PDF
93. PD-L1 upregulation by lytic induction of Epstein-Barr Virus.
- Author
-
Yanagi Y, Hara Y, Mabuchi S, Watanabe T, Sato Y, Kimura H, and Murata T
- Subjects
- B7-H1 Antigen metabolism, Cell Line, Cells, Cultured, Epstein-Barr Virus Infections metabolism, Epstein-Barr Virus Nuclear Antigens genetics, Gene Knockdown Techniques, Humans, NF-kappa B metabolism, Proto-Oncogene Proteins c-akt metabolism, Signal Transduction, Up-Regulation, Viral Proteins genetics, B7-H1 Antigen genetics, Epstein-Barr Virus Infections genetics, Epstein-Barr Virus Infections virology, Gene Expression Regulation, Herpesvirus 4, Human physiology, Host-Pathogen Interactions genetics
- Abstract
Epstein-Barr virus (EBV) is an etiologic agent of infectious mononucleosis and several malignancies. Here, we found that reactivation of EBV resulted in increased programmed cell death-ligand 1 (PD-L1) expression in a cell type-dependent manner. Lytic induction in EBV-positive Akata, AGS, MutuI, and Jijoye cell lines increased PD-L1 levels, but cells such as EBV-negative Akata, MutuIII, and P3HR1 did not have increased PD-L1. EBV in the P3HR1 cell line has a deletion in the EBNA2 gene, while EBV in its parental cell line, Jijoye, has the complete EBNA2 gene. PD-L1 expression by lytic induction was reduced when EBNA2 was knocked down. In addition, pharmacological inhibition indicated involvement of nuclear factor kappa B, mitogen-activated protein kinase, and AKT signaling. These results suggest that EBV likely evades immunity by inducing PD-L1 upon reactivation, through the increased expression of EBNA2 and activation of signaling pathways., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
94. Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review.
- Author
-
Karasawa Y, Mabuchi S, Matsumoto Y, Umemoto M, Miyazaki A, Watanabe A, Okura R, Atsumi R, Sakurai K, Shibuya T, and Kitada F
- Abstract
An arterioenteric fistula is a devastating and life-threatening condition. As patients often present in extremis from hemorrhage shock, an early diagnosis and prompt life-saving interventions have to be performed. In this report, we describe a case of a 38-year-old Japanese woman who presented with hematochezia that rapidly progressed to hemorrhagic shock secondary to an iliac artery-enteric fistula that developed during bevacizumab-containing chemotherapy for recurrent cervical cancer. The patient underwent successful endovascular treatment with a covered stent-graft as a bridge to definitive open surgery., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
95. How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
- Author
-
Singh S, McNab C, Olson RM, Bristol N, Nolan C, Bergstrøm E, Bartos M, Mabuchi S, Panjabi R, Karan A, Abdalla SM, Bonk M, Jamieson M, Werner GK, Nordström A, Legido-Quigley H, and Phelan A
- Subjects
- Animals, COVID-19 transmission, China epidemiology, Disease Outbreaks, Global Health legislation & jurisprudence, Humans, Information Dissemination, International Cooperation, International Health Regulations, Risk Assessment, SARS-CoV-2 isolation & purification, Time Factors, World Health Organization, Zoonoses virology, COVID-19 epidemiology, Pandemics
- Abstract
Understanding the spread of SARS-CoV-2, how and when evidence emerged, and the timing of local, national, regional, and global responses is essential to establish how an outbreak became a pandemic and to prepare for future health threats. With that aim, the Independent Panel for Pandemic Preparedness and Response has developed a chronology of events, actions, and recommendations, from December, 2019, when the first cases of COVID-19 were identified in China, to the end of March, 2020, by which time the outbreak had spread extensively worldwide and had been characterised as a pandemic. Datapoints are based on two literature reviews, WHO documents and correspondence, submissions to the Panel, and an expert verification process. The retrospective analysis of the chronology shows a dedicated initial response by WHO and some national governments, but also aspects of the response that could have been quicker, including outbreak notifications under the International Health Regulations (IHR), presumption and confirmation of human-to-human transmission of SARS-CoV-2, declaration of a Public Health Emergency of International Concern, and, most importantly, the public health response of many national governments. The chronology also shows that some countries, largely those with previous experience with similar outbreaks, reacted quickly, even ahead of WHO alerts, and were more successful in initially containing the virus. Mapping actions against IHR obligations, the chronology shows where efficiency and accountability could be improved at local, national, and international levels to more quickly alert and contain health threats in the future. In particular, these improvements include necessary reforms to international law and governance for pandemic preparedness and response, including the IHR and a potential framework convention on pandemic preparedness and response., Competing Interests: Declaration of interests AP has worked as a consultant with WHO on unrelated projects; was a member of a WHO Technical Advisory Group related to the IHR and COVID-19; is principal investigator in a project funded by the Carnegie Corporation to examine legal elements of a potential pandemic treaty (grant number G-21-58414); and is principal investigator of a project funded by the US Centers for Disease Control to examine national responses to COVID-19 (grant number NU2HGH2021000469: Component 3). HL-Q has worked as a consultant with WHO on unrelated projects and is a member of the WHO Europe High Level Expert Consultation Group on COVID-19 strategies. MBa has worked as a consultant with WHO on projects concerning gaps in pandemic preparedness, a global hub for pandemic and epidemic intelligence, and investment in WHO. RMO has previously worked as a Consultant for WHO with the Violence Against Women Team on unrelated topics. MBo has worked as a consultant with WHO on unrelated projects. CM has worked as a consultant with WHO on unrelated projects and worked full time at the WHO Headquarters from 2000 to 2008. SMA has worked as a consultant with WHO on unrelated projects and is the Lead Project Director of a grant from The Rockefeller Foundation to examine the intersection of data, determinants of health, and decision making. NB has worked as a consultant to WHO through the Global Preparedness Monitoring Board, on a project related to polio assets and COVID-19, and on unrelated topics; and is consulting with the Nuclear Threat Initiative and Johns Hopkins University as they develop the Global Health Security Index (2021). SM has worked with the World Bank to help accelerate their COVID-19 rapid response, and as a Senior Advisor with the Bill and Melinda Gates Foundation. AN has worked as a staff member at WHO, including as Acting Director General and as a Country Representative; and worked as the Ambassador for Global Health for the Government of Sweden before being appointed to lead the Independent Panel secretariat. AK has done unpaid work for the Biden-Harris campaign on COVID-19 related school reopenings, and worked as an unpaid medical fellow on the Massachusetts Department of Public Health COVID-19 response. RP is the US Global Malaria Coordinator at the US Agency for International Development, but his views in this paper are based on his work with the Independent Panel, in which he served until Jan 31, 2021. GKW has served on the UN's High-Level Commission on Health Employment and Economic Growth. The views expressed herein do not necessarily reflect the views of the US Government or its departments and agencies. All other authors declare no competing interests., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
96. The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy.
- Author
-
Mabuchi S, Shimura K, and Matsumoto Y
- Subjects
- Disease-Free Survival, Female, Humans, Japan epidemiology, Middle Aged, Neoplasm Recurrence, Local epidemiology, Neoplasm Recurrence, Local physiopathology, Peritoneum physiopathology, Prognosis, Radiotherapy methods, Radiotherapy statistics & numerical data, Retrospective Studies, Uterine Cervical Neoplasms epidemiology, Uterine Cervical Neoplasms therapy, Neoplasm Recurrence, Local surgery, Peritoneum abnormalities, Uterine Cervical Neoplasms mortality
- Abstract
Objective: To retrospectively evaluated the prognostic significance of post-radiotherapy parametrial involvement (PMI), the necessity of parametrial resection, and the optimal salvage surgery in locally recurrent or persistent cervical cancer developed after radiotherapy., Methods: Patients who developed recurrent or persistent cervical cancer in a previously irradiated field and were subsequently treated with salvage surgery were identified, and the prognostic impact of post-radiotherapy PMI on patient's survival was first investigated. Then, the optimal salvage surgery for patients with post-radiotherapy PMI as well as the predictors for post-radiotherapy PMI were evaluated., Results: A total of 60 patients underwent salvage surgery for recurrent or persistent diseases. Of these, 21 (35.0%) showed post-radiotherapy PMI (PMI-group). Patients in PMI-group showed significantly shorter progression-free survival (PFS) than those in non-PMI-group (p = 0.01). In both PMI-group and non-PMI-group, PFS was affected by the completeness of salvage surgery. In non-PMI-group, less radical surgery achieved similar therapeutic efficacy to more radical surgery (3-year PFS rates: 62.5% versus 54.1%, p = 0.91). In contrast, in PMI-group, not less radical surgery but more radical surgery achieved curative therapeutic efficacy (3-year PFS rate: 0% versus 28.9%). Maximum tumor diameter, deep stromal invasion, and LVSI were found to be predictors of post-radiotherapy PMI., Conclusion: Post-radiotherapy PMI is an indicator of short survival after salvage surgery in patients with locally recurrent or persistent cervical cancer developed after radiotherapy. Both less radical and more radical surgery have curative therapeutic efficacies in patients without post-radiotherapy PMI, if the tumor could be resected with an adequate surgical margin. Thus, hysterectomy type should be tailored to the risk for post-radiotherapy PMI., Competing Interests: Declaration of Competing Interest The authors have no conflicts of interest., (Copyright © 2021. Published by Elsevier Masson SAS.)
- Published
- 2021
- Full Text
- View/download PDF
97. Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response.
- Author
-
Ramchandani R, Kazatchkine M, Liu J, Sudan P, Dybul M, Matsoso P, Nordström A, Phelan A, Legido-Quigley H, Singh S, and Mabuchi S
- Subjects
- Antiviral Agents therapeutic use, COVID-19 prevention & control, Cytidine analogs & derivatives, Cytidine therapeutic use, Global Health, Health Policy, Health Services Accessibility, Humans, Hydroxylamines therapeutic use, Oxygen Inhalation Therapy methods, Pandemics prevention & control, Public Health, SARS-CoV-2, World Health Organization, COVID-19 diagnosis, COVID-19 therapy, COVID-19 Vaccines therapeutic use, Communicable Disease Control methods
- Abstract
Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. The secretariat of the Independent Panel for Pandemic Preparedness and Response is independent.
- Published
- 2021
- Full Text
- View/download PDF
98. National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic.
- Author
-
Jung AS, Haldane V, Neill R, Wu S, Jamieson M, Verma M, Tan M, De Foo C, Abdalla SM, Shrestha P, Chua AQ, Bristol N, Singh S, Bartos M, Mabuchi S, Bonk M, McNab C, Werner GK, Panjabi R, Nordström A, and Legido-Quigley H
- Subjects
- COVID-19 prevention & control, COVID-19 Vaccines therapeutic use, Health Inequities, Health Policy, Humans, Masks, Physical Distancing, Politics, SARS-CoV-2, Time Factors, Travel, Uncertainty, COVID-19 epidemiology, Pandemics, Public Health
- Abstract
Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have no interests to declare.
- Published
- 2021
- Full Text
- View/download PDF
99. Prognostic significance of tumor laterality in advanced ovarian cancer.
- Author
-
Yamada Y, Mabuchi S, Kawahara N, and Kawaguchi R
- Abstract
Objective: This study aimed to investigate the effect of incorporating tumor laterality into the International Federation of Gynecology and Obstetrics (FIGO) staging system for advanced ovarian cancer., Methods: The clinical data of 131 patients with advanced ovarian cancer treated between 2008 and 2018 were retrospectively reviewed. To investigate the prognostic significance of tumor laterality, we divided the patients into unilateral and bilateral groups. The prognostic significance of tumor laterality (bilateral vs. unilateral) was evaluated using univariate and multivariate analyses. The effect of incorporating tumor laterality into the FIGO staging system to predict survival outcomes was evaluated using the Kaplan-Meier method., Results: Both overall survival (OS) and progression-free survival (PFS) were longer in the unilateral group than in the bilateral group. Multivariate analysis demonstrated that tumor laterality was an independent predictor of OS (hazard ratio, 1.75; confidence interval, 1.05-2.92; P=0.032). In patients with stage III disease, the bilateral group had a shorter OS than the unilateral group, but it was comparable to the OS in stage IV patients (P=0.354). The incorporation of tumor laterality into the FIGO staging system improved the stratification of survival probabilities., Conclusion: Tumor laterality can be an independent prognostic factor in patients with advanced ovarian cancer. The incorporation of tumor laterality may improve the predictive performance of the FIGO staging system in patients with advanced ovarian cancer.
- Published
- 2021
- Full Text
- View/download PDF
100. The first case of recurrent small cell neuroendocrine carcinoma of the uterine cervix successfully treated with robotic-assisted super radical hysterectomy.
- Author
-
Mabuchi S and Waki K
- Abstract
Recurrent cervical cancer occurring in a previously irradiated field is one of the most complicated challenges for gynecological oncologists. Super-radical hysterectomy is a standard procedure for laterally extended cervical tumors, particularly recurrent cervical cancer in a previously irradiated field. This potentially curative procedure is challenging to perform due to the technical complexities and lack of reproducibility. Thus, it is performed only by skilled surgeons, either via open or laparoscopic approaches wherein the entire paracervix at the pelvic wall and the hypogastric vessels are transected. In this report, we described the first case of recurrent small cell neuroendocrine carcinoma of the uterine cervix that was successfully treated with robot-assisted super-radical hysterectomy., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.